Measuring population ageing: an analysis of the Global Burden of Disease Study 2017.

Chang AY, Skirbekk VF, Tyrovolas S, Kassebaum NJ, Dieleman JL. · 2019

Read Measuring population ageing: an analysis of the Global Burden of Disease Study 2017. by Chang AY, Skirbekk VF, Tyrovolas S, Kassebaum NJ, Dieleman JL. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6472541.txt.

Introduction

Chang and co-authors build a new measure of population ageing from Global Burden of Disease 2017 data, one that counts healthy years rather than birthdays alone. They first identified 92 diseases whose incidence climbs steeply with age; together those diseases made up 51.3 percent of all adult health burden in 2017.

Each country's burden was then converted into an equivalent age, the age at which an average global population carries the same load. The spread was startling: 76.1 years in Japan against 45.6 in Papua New Guinea. Age-related burden rates ran from 137.8 DALYs per 1,000 adults in rich countries to 265.9 in poor ones, though rates fell everywhere between 1990 and 2017.

Catalog record

CREATORChang AY, Skirbekk VF, Tyrovolas S, Kassebaum NJ, Dieleman JL.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE46 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6472541

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Measuring population ageing: an analysis of the Global Burden of Disease Study 2017 By Angela Y Chang, Vegard F Skirbekk, Stefanos Tyrovolas, Nicholas J Kassebaum, Joseph L Dieleman Published in: The Lancet. Public Health DOI: 10.1016/S2468-2667(19)30019-2 ABSTRACT Summary Background Traditional metrics for population health ageing tend not to differentiate between extending life expectancy and adding healthy years. A population ageing metric that reflects both longevity and health status, incorporates a comprehensive range of diseases, and allows for comparisons across countries and time is required to understand the progression of ageing and to inform policies. Methods Using the Global Burden of Diseases, Injuries, and Risk Factors Study 2017, we developed a metric that reflects age-related morbidity and mortality at the population level. First, we identified a set of age-related diseases, defined as diseases with incidence rates among the adult population increasing quadratically with age, and measured their age-related burden, defined as the sum of disability-adjusted life-years (DALYs) of these diseases among adults. Second, we estimated age-standardised age-related health burden across 195 countries between 1990 and 2017. Using global average 65-year-olds as the reference population, we calculated the equivalent age in terms of age-related disease burden for all countries. Third, we analysed how the changes in age-related burden during the study period relate to different factors with a decomposition analysis. Finally, we describe how countries with similar levels of overall age-related burden experience different onsets of ageing. We represent the uncertainty of our estimates by calculating uncertainty intervals (UI) from 1000 draw-level estimates for each disease, country, year, and age. Findings 92 diseases were identified as age related, accounting for 51·3% (95% UI 48·5–53·9) of all global burden among adults in 2017. Across the Socio-demographic Index (SDI), the rate of age-related burden ranged from 137·8 DALYs (128·9–148·3) per 1000 adults in high SDI countries to 265·9 DALYs (251·0–280·1) in low SDI countries. The equivalent age to average 65-year-olds globally spanned from 76·1 years (75·6–76·7) in Japan to 45·6 years (42·6–48·2) in Papua New Guinea. Age-standardised age-related disease rates have decreased over time across all SDI levels and regions between 1990 and 2017, mainly due to decreases in age-related case fatality and disease severity. Even among countries with similar age-standardised death rates, large differences in the onset and patterns of accumulating age-related burden exist. Interpretation The new metric facilitates the shift from thinking not just about chronological age but the health status and disease severity of ageing populations. Our findings could provide inputs into policymaking by identifying key drivers of variation in the ageing burden and resources required for addressing the burden. Funding National Institute on Aging of the National Institutes of Health. INTRODUCTION Governments worldwide are moving with urgency to introduce policies that address population ageing. Whether increased longevity is an opportunity or a threat to the stability of societies largely depends not only on whether populations are living longer but whether they are experiencing the negative health effects of ageing—a progressive loss of physical, mental, and cognitive integrity, leading to impaired functions and increased vulnerability to morbidity and mortality.1, 2 It is therefore crucial that we measure the extent to which ageing and age-related disease burden occurs in a population over time to inform better policies. In existing public health literature, there are two main approaches to measuring ageing. The first and most common set of ageing metrics involves measuring changes in the age structure but fails to capture the level of morbidity of the population.3 They include metrics such as the shift in the population's age distribution toward older ages,4 increase in the population's median age,5 increase in average life expectancy,4, 6 number of remaining years left to live, and changes in the ratio between what are classed as older and working age groups.7 The second main set of literature focuses on measuring the functional status of older populations, using objective measures such as biomarkers,8 frailty,9, 10, 11 and cognitive functioning12 or subjective measures such as self-reported health and instrumental limitations of activities of daily living. These studies, in our view, more accurately capture the health status of individuals and reflect the heterogeneity in how people age. However, the studies often involve complex, resource-intensive study designs, are conducted among a relatively small sample, and might not be generalisable or comparable across study settings. The measures are often not identical or similarly understood and tested across study populations or over time, making these studies and the longitudinal waves difficult to compare or to be aggregated into population-level metrics.13, 14, 15 Another challenge is that none of these studies and measures take most diseases and their severity into account. Research in contextEvidence before this studyWe searched PubMed, Google Scholar, and publicly available grey literature for the terms “ageing”, functioning”, “frailty”, “measurement”, and “metric” on May 1, 2018, without language or field restrictions. We further consulted with well recognised experts in this field for literature recommendations. We found that in both academic and policy communities, population ageing, including the measurement and promotion of concepts such as so-called healthy or successful ageing has been an ongoing interest for several decades. Some of the most common metrics of population ageing entail descriptions of increased longevity (such as rising life expectancy at older ages) and changes in the distribution of age groups (such as median age, proportion of older populations, and old-age dependency ratio). Many define old age by setting a universal age threshold, often originating from social policies or norms such as retirement ages, and consider all individuals above this age threshold as older populations. WHO and the UN Population Division commonly apply the age thresholds of age 60, 65, or 70 years. However, the age at which one is considered an older person should be based on objective measures and should take into account the health status of the individuals, including whether population ageing is accompanied by improvements or deterioration in health.Added value of this studyThe Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides estimation of health burden for a comprehensive and comparable list of diseases across time and geographies and offers a framework through which the limitations in current measures of population ageing can be addressed. First, using disability-adjusted life-years of age-related diseases of all adults to measure population ageing, our approach captures both the longevity and health of populations and avoids setting arbitrary age thresholds to define older populations. Second, given the consistent and systematic approaches taken by GBD in measuring health outcomes, we can compare changes in age-related disease burden across countries and over time and assess different factors that have led to changes over time. Finally, using GBD's age-specific health estimates, we are able to capture at which ages the burden of age-related diseases start to accumulate and compare results among countries with similar levels of overall age-related disease burden to explore whether some have an earlier onset of ageing burden than others.Implications of all the available evidenceGlobally, age-standardised age-related disease burden among adults has declined since 1990. While the number of adults and the median age of adults have increased over time, we estimated large declines in case fatality and disease severity of age-related diseases. We also found wide variations in the levels, trends, and the

Read the complete text